These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23185800)

  • 1. Diagnostic value of thrombocytosis and high CA 125 level in women with adnexal masses.
    Atacag T
    Eur J Gynaecol Oncol; 2012; 33(5):517-20. PubMed ID: 23185800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of the preoperative platelet count in the diagnosis of adnexal tumors.
    Watrowski R; Heinze G; Jäger C; Forster J; Zeillinger R
    Tumour Biol; 2016 Sep; 37(9):12079-12087. PubMed ID: 27207344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Risk of Malignancy Index in daily clinical management of adnexal masses.
    van den Akker PA; Aalders AL; Snijders MP; Kluivers KB; Samlal RA; Vollebergh JH; Massuger LF
    Gynecol Oncol; 2010 Mar; 116(3):384-8. PubMed ID: 19959215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-dimer as a tumor marker in pre-operative assessment of adnexal masses.
    Worasethsin P; Narkwichean A
    J Med Assoc Thai; 2013 Nov; 96(11):1395-400. PubMed ID: 24428087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy and cost-effectiveness of different strategies to triage women with adnexal masses: a prospective study.
    Piovano E; Cavallero C; Fuso L; Viora E; Ferrero A; Gregori G; Grillo C; Macchi C; Mengozzi G; Mitidieri M; Pagano E; Zola P
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):395-403. PubMed ID: 27706929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of malignancy index for adnexal masses.
    Akdeniz N; Kuyumcuoğlu U; Kale A; Erdemoğlu M; Caca F
    Eur J Gynaecol Oncol; 2009; 30(2):178-80. PubMed ID: 19480249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women.
    Holcomb K; Vucetic Z; Miller MC; Knapp RC
    Am J Obstet Gynecol; 2011 Oct; 205(4):358.e1-6. PubMed ID: 21722869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of malignancy index in the evaluation of patients with adnexal masses.
    Clarke SE; Grimshaw R; Rittenberg P; Kieser K; Bentley J
    J Obstet Gynaecol Can; 2009 May; 31(5):440-5. PubMed ID: 19604425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of the adapted Risk of Malignancy Index incorporating tumor size in the preoperative evaluation of adnexal masses.
    van den Akker PA; Zusterzeel PL; Aalders AL; Snijders MP; Samlal RA; Vollebergh JH; Kluivers KB; Massuger LF
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):422-5. PubMed ID: 21824712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Probably Benign Adnexal Masses in Postmenopausal Women.
    Karakaya BK; Ozgu E; Kansu HC; Evliyaoglu O; Sarikaya E; Coskun B; Erkaya S
    Rev Bras Ginecol Obstet; 2017 May; 39(5):229-234. PubMed ID: 28346954
    [No Abstract]   [Full Text] [Related]  

  • 11. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
    Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
    Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CEA in evaluation of adnexal mass: retrospective cohort analysis and review of the literature.
    Sagi-Dain L; Lavie O; Auslander R; Sagi S
    Int J Biol Markers; 2015 Nov; 30(4):e394-400. PubMed ID: 26109367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of applicability of HE4 and ROMA in the preoperative diagnosis of adnexal masses].
    Janas L; Głowacka E; Wilczyński JR; Malinowski A; Nowak M
    Ginekol Pol; 2015 Mar; 86(3):193-7. PubMed ID: 25920309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of adnexal masses in premenopausal patients: a ten-year retrospective study at a single center.
    Ozcan HC; Balat O; Ugur MG; Kul S; Bozdag Z; Sucu S; Keklikcioglu I
    Eur J Gynaecol Oncol; 2017; 38(3):372-377. PubMed ID: 29693876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors.
    Gungor T; Kanat-Pektas M; Sucak A; Mollamahmutoglu L
    Arch Gynecol Obstet; 2009 Jan; 279(1):53-6. PubMed ID: 18470520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ovarian cancers in geriatric population: the validity of inflammatory markers, malignancy risk indices 1, 2, 3, 4, and CA-125 levels in malignancy discrimination of adnexal masses.
    Vural F; Aka N; Ertas S; Kose G; Tufekci EC
    Eur J Gynaecol Oncol; 2016; 37(6):846-851. PubMed ID: 29943934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and Management of Adnexal Masses.
    Biggs WS; Marks ST
    Am Fam Physician; 2016 Apr; 93(8):676-81. PubMed ID: 27175840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mean of CA 125 in making therapy decision in adnexal inflammatory tumors.
    Nikolić B; Mitrović A; Lazić J
    Bosn J Basic Med Sci; 2006 May; 6(2):3-6. PubMed ID: 16879104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application values of four risk of malignancy indices in the preoperative evaluation of patients with adnexal masses].
    Lou HY; Meng H; Zhu QL; Zhang Q; Jiang YX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Jun; 32(3):297-302. PubMed ID: 20602883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do preoperative serum vascular endothelial growth factor and migration-inhibitory factor predict the nature of the adnexal masses? A prospective-controlled trial.
    Yildirim N; Dikmen Y; Terek MC; Akman L; Gunel NS; Aktan C; Zekioglu O; Gunduz C
    J Obstet Gynaecol; 2016 May; 36(4):533-7. PubMed ID: 26758243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.